A porous matrix suitable for use as a tissue scaffold is described. The matrix may be shaped before insertion into or at the target tissue site, or injected via a minimally invasive method. The matrix may be pre-seeded with cells of the target tissue or may be used to support growth of the local end
A porous matrix suitable for use as a tissue scaffold is described. The matrix may be shaped before insertion into or at the target tissue site, or injected via a minimally invasive method. The matrix may be pre-seeded with cells of the target tissue or may be used to support growth of the local endogenous tissue. The matrix may contain growth factors or other pharmacologically acceptable moieties such as antibiotics.
대표청구항▼
1. A porous polymeric composition in particulate or powder form, comprising: a first phase comprising a first polymer and a plasticizer selected from the group consisting of polyethylene glycol (PEG), polypropylene glycol, polycaprolactone, low molecular weight oligomers of polyethylene glycol (PEG)
1. A porous polymeric composition in particulate or powder form, comprising: a first phase comprising a first polymer and a plasticizer selected from the group consisting of polyethylene glycol (PEG), polypropylene glycol, polycaprolactone, low molecular weight oligomers of polyethylene glycol (PEG), polypropylene glycol, or polycaprolactone, adipates, phosphates, phthalates, sabacates, azelates, citrates, poly lactides, and poly lactide-co-glycolide;a second phase comprising a second polymer,wherein either the first or the second phase has a glass transition temperature of <45° C.,wherein the composition forms a porous matrix when the phase having a glass transition temperature of <45° C. is heated to a temperature above its glass transition temperature above and mixed with the other phase,wherein the first and the second polymers are selected from the group consisting of poly([a]-hydroxyacids), polylactic or polyglycolic acids, poly-lactide poly-glycolide copolymers, poly-lactide polyethylene glycol (PEG) copolymers, polyesters, poly ([epsilon]-caprolactone), poly (3-hydroxy-butyrate), poly (s-caproic acid), poly (p-dioxanone), poly (propylene fumarate), poly (ortho esters), polyol/diketene acetals addition polymers, polyanhydrides, poly (sebacic anhydride) PSA), poly(carboxybiscarboxyphenoxyphenoxy hexane) (PCPP), poly rbis (p-carboxyphenoxy) methanel (PCPM), copolymers of SA, CPP and CPM poly (amino acids), poly (pseudo amino acids), polyphosphazenes, derivatives of poly [(dichloro) phosphazene], poly [(organo) phosphazenes] polymers, polyphosphates, polyethylene glycol polypropylene block copolymers, natural polymers, silk, elastin, chitin, chitosan, fibrin, fibrinogen, polysaccharides (including pectins), alginates, collagen, poly (amino acids), peptides, polypeptides, proteins, co-polymers prepared from the monomers of these polymers, or mixtures thereof. 2. The composition according to claim 1, wherein the mixture of the first and second phase is porous and further incorporates cells from a target tissue site. 3. The composition according to claim 1, wherein the second phase is porous. 4. The composition according to claim 3, wherein the second phase has a porosity of from 10% to 97%. 5. The composition according to claim 1, wherein each polymer is biodegradable. 6. The composition according to claim 1, wherein the second phase is porous and further incorporates cells therein from a target tissue site. 7. The composition according to claim 1, further comprising cells. 8. The composition according to claim 1, further comprising one or more factors useful for promotion of tissue growth and development. 9. The composition according to claim 1, wherein the first and the second phase each further comprises drugs, hormones, enzymes, antibiotics, or nutrients, or mixtures thereof. 10. The composition according to claim 9, wherein drugs, hormones, enzymes, antibiotics, or nutrients, or mixtures thereof that are comprised within the first phase are different than those comprised within the second phase. 11. The composition of claim 1, wherein the first polymer is the same as the second polymer.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (56)
Polson Alan M. (Fort Collins CO) Swanbom Deryl D. (Fort Collins CO) Dunn Richard L. (Fort Collins CO) Cox Charles P. (Fort Collins CO) Norton Richard L. (Fort Collins CO) Lowe Bryan K. (Fort Collins , Apparatus for forming a biodegradable implant precursor.
Barrows Thomas H. (Cottage Grove MN) Truong Myhanh T. (Blaine MN) Suszko Paul R. (Cottage Grove MN), Biocompatible porous matrix of bioabsorbable material.
Tipton Arthur J. (Birmingham AL) Fujita Shawn M. (Amsterdam NLX) Dunn Richard L. (Fort Collins CO), Biodegradable film dressing and method for its formation.
Alan M. Polson ; Deryl D. Swanbom ; Richard L. Dunn ; Charles P. Cox ; Richard L. Norton ; Bryan K. Lowe ; Kenneth S. Peterson, Biodegradable implant precursor.
Polson Alan M. (Fort Collins CO) Swanbom Deryl D. (Fort Collins CO) Dunn Richard L. (Fort Collins CO) Cox Charles P. (Fort Collins CO) Norton Richard L. (Fort Collins CO) Lowe Bryan K. (Fort Collins , Biodegradable implant precursor.
Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David D. (Birmingham AL), Biodegradable in-situ forming implants and methods for producing the same.
Dunn Richard L. (451 Boardwalk Dr. RLD ; Apt. 501 Fort Collins CO 80526) English James P. (2500 Melinda Cir. Birmingham AL 35214) Cowsar Donald R. (4657 Round Forest Dr. Birmingham AL 35213) Vanderbi, Biodegradable in-situ forming implants and methods of producing the same.
Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David D. (Birmingham AL), Biodegradable in-situ forming implants and methods of producing the same.
Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David P. (Birmingham AL), Biodegradable in-situ forming implants and methods of producing the same.
Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable polymer composition.
Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable polymer composition.
Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable system for regenerating the periodontium.
Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable system for regenerating the periodontium.
Polson Alan M. ; Swanbom Deryl D. ; Dunn Richard L. ; Cox Charles P. ; Norton Richard L. ; Lowe Bryan K. ; Peterson Kenneth S., Method and composition for treating a bone tissue defect.
Lee Dosuk D. ; Rey Christian,FRX ; Aiolova Maria ; Tofighi Aliassghar, Methods and products related to the physical conversion of reactive amorphous calcium phosphate.
Gagnon David R. (St. Paul MN) Coleman Patrick L. (Minneapolis MN) Ortina Gary J. (Woodbury MN) Lyons Christopher S. (St. Paul MN) Milbrath Dean S. (West Lakeland Township ; Washington County MN) Rasm, Porous supports having azlactone-functional surfaces.
Vyakarnam, Murty N.; Zimmerman, Mark C.; Scopelianos, Angelo George; Roller, Mark B.; Gorky, David V., Porous tissue scaffoldings for the repair or regeneration of tissue.
Langer Robert S. ; Elisseeff Jennifer H. ; Anseth Kristi ; Sims Derek, Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.